| description |
Haploinsufficiency for the erythroid-specific transcription factor KLF1 is associated with hereditary persistence of fetal hemoglobin (HPFH). Increased HbF ameliorates the symptoms of -hemoglobinopathies and downregulation of KLF1 activity has been proposed as a potential therapeutic strategy. However, the feasibility of this approach has been challenged by the observation that KLF1 haploinsufficient individuals with the same KLF1 variant, within the same family, display a wide range of HbF levels. This phenotypic variability is not readily explained by co-inheritance of known HbF-modulating variants in the HBB, HBS1L-MYB and/or BCL11A loci. We studied Maltese individuals in which KLF1 p.K288X carriers display HbF levels ranging between 1.6-12.5% of total Hb. Using a combination of gene expression analysis, chromatin accessibility assays and promoter activity tests we find that allelic variation of wildtype KLF1 may explain a significant part of the variability in HbF levels observed in KLF1 p.K288X carriers. Our results have general bearing on the variable penetrance of haploinsufficiency phenotypes and on conflicting interpretations of pathogenicity of variants in other transcriptional regulators such as EP300, GATA2 and RUNX1. |